1-235809132-C-G

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2

The NM_000081.4(LYST):​c.1686G>C​(p.Gln562His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00571 in 1,614,118 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0038 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0059 ( 35 hom. )

Consequence

LYST
NM_000081.4 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7

Conservation

PhyloP100: 0.00800
Variant links:
Genes affected
LYST (HGNC:1968): (lysosomal trafficking regulator) This gene encodes a protein that regulates intracellular protein trafficking in endosomes, and may be involved in pigmentation. Mutations in this gene are associated with Chediak-Higashi syndrome, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants, though the full-length nature of some of these variants has not been determined. [provided by RefSeq, Apr 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), LYST. . Trascript score misZ 4.0845 (greater than threshold 3.09). GenCC has associacion of gene with Chediak-Higashi syndrome, attenuated Chédiak-Higashi syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.009939283).
BP6
Variant 1-235809132-C-G is Benign according to our data. Variant chr1-235809132-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 254913.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=6, Benign=1, Uncertain_significance=1}. Variant chr1-235809132-C-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00376 (573/152316) while in subpopulation NFE AF= 0.00604 (411/68012). AF 95% confidence interval is 0.00556. There are 0 homozygotes in gnomad4. There are 263 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 35 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LYSTNM_000081.4 linkuse as main transcriptc.1686G>C p.Gln562His missense_variant 5/53 ENST00000389793.7 NP_000072.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LYSTENST00000389793.7 linkuse as main transcriptc.1686G>C p.Gln562His missense_variant 5/535 NM_000081.4 ENSP00000374443 P1Q99698-1

Frequencies

GnomAD3 genomes
AF:
0.00376
AC:
573
AN:
152198
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00113
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00275
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00631
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00604
Gnomad OTH
AF:
0.00287
GnomAD3 exomes
AF:
0.00379
AC:
950
AN:
250868
Hom.:
2
AF XY:
0.00393
AC XY:
533
AN XY:
135564
show subpopulations
Gnomad AFR exome
AF:
0.00142
Gnomad AMR exome
AF:
0.000897
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00111
Gnomad FIN exome
AF:
0.00596
Gnomad NFE exome
AF:
0.00625
Gnomad OTH exome
AF:
0.00376
GnomAD4 exome
AF:
0.00591
AC:
8644
AN:
1461802
Hom.:
35
Cov.:
35
AF XY:
0.00576
AC XY:
4190
AN XY:
727206
show subpopulations
Gnomad4 AFR exome
AF:
0.000777
Gnomad4 AMR exome
AF:
0.00105
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00114
Gnomad4 FIN exome
AF:
0.00614
Gnomad4 NFE exome
AF:
0.00706
Gnomad4 OTH exome
AF:
0.00465
GnomAD4 genome
AF:
0.00376
AC:
573
AN:
152316
Hom.:
0
Cov.:
32
AF XY:
0.00353
AC XY:
263
AN XY:
74472
show subpopulations
Gnomad4 AFR
AF:
0.00113
Gnomad4 AMR
AF:
0.00275
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00631
Gnomad4 NFE
AF:
0.00604
Gnomad4 OTH
AF:
0.00284
Alfa
AF:
0.00479
Hom.:
0
Bravo
AF:
0.00338
TwinsUK
AF:
0.00728
AC:
27
ALSPAC
AF:
0.00856
AC:
33
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00442
AC:
38
ExAC
AF:
0.00417
AC:
506
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00715
EpiControl
AF:
0.00628

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Chédiak-Higashi syndrome Uncertain:1Benign:3
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingAl Jalila Children’s Genomics Center, Al Jalila Childrens Speciality HospitalMar 30, 2020- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Uncertain significance, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesSep 13, 2022- -
not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenFeb 01, 2024LYST: BP4 -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Autoinflammatory syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenMar 25, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
14
DANN
Uncertain
1.0
DEOGEN2
Benign
0.21
T;.
Eigen
Benign
-0.16
Eigen_PC
Benign
-0.22
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.92
D;D
M_CAP
Benign
0.035
D
MetaRNN
Benign
0.0099
T;T
MetaSVM
Benign
-0.71
T
MutationAssessor
Benign
1.6
L;.
MutationTaster
Benign
0.97
D;D;D
PrimateAI
Benign
0.40
T
PROVEAN
Uncertain
-2.4
N;N
REVEL
Benign
0.096
Sift
Uncertain
0.027
D;D
Sift4G
Uncertain
0.0040
D;D
Polyphen
0.71
P;.
Vest4
0.46
MutPred
0.30
Gain of relative solvent accessibility (P = 0.09);Gain of relative solvent accessibility (P = 0.09);
MVP
0.65
MPC
0.13
ClinPred
0.023
T
GERP RS
-0.37
Varity_R
0.13
gMVP
0.43

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs77091385; hg19: chr1-235972432; COSMIC: COSV101090314; API